HeartSciences (HSCS) Cash from Operations (2021 - 2026)
HeartSciences filings provide 6 years of Cash from Operations readings, the most recent being 1462526.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 9.73% to 1462526.0 in Q1 2026 year-over-year; TTM through Jan 2026 was 7340799.0, a 0.79% increase, with the full-year FY2025 number at 7412994.0, down 22.12% from a year prior.
- Cash from Operations hit 1462526.0 in Q1 2026 for HeartSciences, up from 2334266.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 966278.0 in Q1 2022 to a low of 2334266.0 in Q4 2025.
- Median Cash from Operations over the past 5 years was 1590640.0 (2025), compared with a mean of 1597971.47.
- Biggest five-year swings in Cash from Operations: tumbled 152.51% in 2022 and later grew 22.89% in 2025.
- HeartSciences' Cash from Operations stood at 1080141.0 in 2022, then grew by 8.51% to 988187.0 in 2023, then tumbled by 120.97% to 2183550.0 in 2024, then fell by 6.9% to 2334266.0 in 2025, then skyrocketed by 37.35% to 1462526.0 in 2026.
- The last three reported values for Cash from Operations were 1462526.0 (Q1 2026), 2334266.0 (Q4 2025), and 1953367.0 (Q3 2025) per Business Quant data.